Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Merayo-Chalico

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Clinical Neurology and Neurosurgery|February 4, 2021
Risk factors for ischemic antiphospholipid syndrome: A case-control studyRoxana Matus-Mayorga, Ana Barrera-Vargas, Marina Rull-Gabayet, et al.
Lupus|May 12, 2020
Hepatic manifestations in systemic lupus erythematosusJosé A González-Regueiro, Mariana Cruz-Contreras, Javier Merayo-Chalico, et al.
The International Journal of Neuroscience|August 9, 2021
Posterior reversible encephalopathy syndrome during convalescence from COVID-19Anaclara Michel-Chávez, Miguel García-Grimshaw, Oswaldo Alan Chávez-Martínez, et al.
Science Advances|October 29, 2020
Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritisLiam J O'Neil, Ana Barrera-Vargas, Donavon Sandoval-Heglund, et al.
The Journal of Rheumatology|January 17, 2019
Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American LandscapeJavier Merayo-Chalico, Ana Barrera-Vargas, Sandra Morales-Padilla, et al.
Frontiers in Immunology|January 30, 2019
The Systemic Lupus Erythematosus Infection Predictive Index (LIPI): A Clinical-Immunological Tool to Predict Infections in Lupus PatientsJiram Torres-Ruiz, Nancy R Mejía-Domínguez, Alejandro Zentella-Dehesa, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 15, 2025
Clinical Characteristics and 1-Year Response in Rheumatic Mexican Patients Using JAK Inhibitors: Data From BIOBADAMEXVijaya Rivera-Terán, Iris Jazmín Colunga-Pedraza, David Vega-Morales, et al.
The Journal of Rheumatology|July 3, 2014
Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhageMarco Ulises Martinez-Martinez, Anne K Sturbaum, Jorge Alcocer-Varela, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 6, 2025
Differences in Clinical Profiles and Biologic Treatment Approaches for Autoimmune Rheumatic Diseases Across Regions in Mexico: An Analysis of the BIOBADAMEX CohortVijaya Rivera Terán, Miguel Ángel Saavedra, Iris Jazmín Colunga Pedraza, et al.
Reumatologia Clinica|April 12, 2026
Prevalence of latent tuberculosis in patients with rheumatological diseases exposed to biologic drugs and small molecules: A study based on the BIOBADAMEX national registryLuis Francisco Valdés Corona, Ana González Andrade, Aylin Luna Salazar, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Clinical Neurology and Neurosurgery|February 4, 2021
Risk factors for ischemic antiphospholipid syndrome: A case-control studyRoxana Matus-Mayorga, Ana Barrera-Vargas, Marina Rull-Gabayet, et al.
Lupus|May 12, 2020
Hepatic manifestations in systemic lupus erythematosusJosé A González-Regueiro, Mariana Cruz-Contreras, Javier Merayo-Chalico, et al.
The International Journal of Neuroscience|August 9, 2021
Posterior reversible encephalopathy syndrome during convalescence from COVID-19Anaclara Michel-Chávez, Miguel García-Grimshaw, Oswaldo Alan Chávez-Martínez, et al.
Science Advances|October 29, 2020
Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritisLiam J O'Neil, Ana Barrera-Vargas, Donavon Sandoval-Heglund, et al.
The Journal of Rheumatology|January 17, 2019
Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American LandscapeJavier Merayo-Chalico, Ana Barrera-Vargas, Sandra Morales-Padilla, et al.
Frontiers in Immunology|January 30, 2019
The Systemic Lupus Erythematosus Infection Predictive Index (LIPI): A Clinical-Immunological Tool to Predict Infections in Lupus PatientsJiram Torres-Ruiz, Nancy R Mejía-Domínguez, Alejandro Zentella-Dehesa, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 15, 2025
Clinical Characteristics and 1-Year Response in Rheumatic Mexican Patients Using JAK Inhibitors: Data From BIOBADAMEXVijaya Rivera-Terán, Iris Jazmín Colunga-Pedraza, David Vega-Morales, et al.
The Journal of Rheumatology|July 3, 2014
Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhageMarco Ulises Martinez-Martinez, Anne K Sturbaum, Jorge Alcocer-Varela, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 6, 2025
Differences in Clinical Profiles and Biologic Treatment Approaches for Autoimmune Rheumatic Diseases Across Regions in Mexico: An Analysis of the BIOBADAMEX CohortVijaya Rivera Terán, Miguel Ángel Saavedra, Iris Jazmín Colunga Pedraza, et al.
Reumatologia Clinica|April 12, 2026
Prevalence of latent tuberculosis in patients with rheumatological diseases exposed to biologic drugs and small molecules: A study based on the BIOBADAMEX national registryLuis Francisco Valdés Corona, Ana González Andrade, Aylin Luna Salazar, et al.
Pageof 5